Jackson Laboratory and NYSCF Form Alliance for Biomedical Research

The Jackson Laboratory (JAX) and The New York Stem Cell Foundation (NYSCF) have announced a significant alliance to advance disease research and accelerate the discovery of therapies. Announced in a press release, this partnership aims to integrate JAX's expertise in genomics and disease modeling with NYSCF's stem cell technologies and data science capabilities.

The collaboration will leverage the NYSCF Global Stem Cell Array®, a robotic platform that automates the creation of patient-specific stem cells, enhancing precision in disease understanding and treatment testing. This integration with JAX's capabilities is expected to unlock new insights into disease mechanisms and therapeutic responses.

The partnership will focus on expanding research efforts in areas such as Alzheimer's, Parkinson's, cancer, diabetes, and rare diseases. The combined organization will be managed from JAX's headquarters in Bar Harbor, Maine, with NYSCF's Manhattan facility continuing as a key site within JAX's global network.